Upcoming treatments for morphea
Abstract Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4–2.7 cases per 100,000. Morphea occurs most frequently in children aged 2–14 years, and the disease exhibits a female predominance. Insights in...
Enregistré dans:
Auteurs principaux: | Dan Wenzel, Nazgol‐Sadat Haddadi, Khashayar Afshari, Jillian M. Richmond, Mehdi Rashighi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c979b079617a4b38afa6c44a5b637f4c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Progesterone Aggravates Lung Fibrosis in a Mouse Model of Systemic Sclerosis
par: Fatemeh Vafashoar, et autres
Publié: (2021) -
Сatalase antibodies in patients with systemic scleroderma as a diagnostic and prognostic marker of the disease
par: O. I. Emelyanova, et autres
Publié: (2021) -
DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
par: O. I. Emelyanova, et autres
Publié: (2019) -
PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1
par: Naoko Takamura, et autres
Publié: (2021) -
Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137+ FOXP3+ Regulatory T Cells Detectable in Peripheral Blood
par: Yi Zhang, et autres
Publié: (2021)